IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
emtricitabine-tenofovir
emtricitabine-tenofovir
Brand names:
Descovy, Truvada
Form
Strength
TABLET, ORAL
200 mg-300 mg
Display
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
,
Nucleosides and Nucleotides
Class:
08180820
,
081832
Medication comments:
HIV Postexposure Prophylaxis
Last updated:
Aug. 15, 2024
Black Box Warnings
Emtricitabine: Lactic acidosis, severe hepatomegaly; hepB co-infection
Black Box Warnings
Tenofovir: lactic acidosis, severe hepatomegaly; hepB co-infection
Black Box Warnings
Lactic Acidosis; severe hepatomegaly; hep B co-infection
REMS
Truvada Tablets
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online